In Vitro susceptibility of diabetic wound bacteria to mixtures of honey, Commiphora molmol and Nigella sativa

Open Nutraceuticals Journal

Volumn 4, Issue , 2011, Pages 172-175

  Alzahrani, Hasan A ^a   Bakhotmah, Balkees A ^a   Boukraâ, Laïd ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF TIARET   (Algeria)

Author keywords

Antibacterial; Commiphora molmol; Diabetes; Nigella sativa

Indexed keywords

ANTIINFECTIVE AGENT; HERBACEOUS AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLACK CUMIN; COMMIPHORA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC FOOT; DRUG EFFICACY; DRUG MIXTURE; ESCHERICHIA COLI; HONEY; HUMAN; HUMAN TISSUE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; WOUND;

BACTERIA (MICROORGANISMS); COMMIPHORA HABESSINICA; NIGELLA SATIVA;

EID: 80053468360     PISSN: None     EISSN: 18763960     Source Type: Journal    
DOI: 10.2174/1876396001104010172     Document Type: Article

References (25)

1. Elhadad TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, Clinical and Complications Profile of Diabetes in Saudi Arabia: A Review. Ann Saudi Med 2007; 4: 241-50.
2. Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 2002; 25(2): 324-9.
3. Garrow D, Egede LE. National patterns and correlates of complementary and alternative medicine use in adults with diabetes. J Altern Complement Med 2006; 12(9): 895-902.
4. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40(3): 163-73.
5. Al Zahrani HA, Ghandourah NM, Merdad HT. Limb Amputations in Western Saudi Arabia. Asian J Surg 1992; 15(3): 119-22.
6. Robbins JM, Strauss G, Aron D, Long J, Kuba J, Kaplan Y. Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? J Am Podiatr Med Assoc 2008; 98(6): 489-93.
7. Zgonis T, Stapleton JJ, Girard-Powell VA, Hagino RT. Surgical management of diabetic foot infections and amputations. AORN J 2008; 87(5): 935-46.
8. Tentoulouris N, Al-Sabbagh S, Walker MG, Boulton AJM, Jude EB. Mortality in Diabetic and non-diabetic patients after amputations performed from 1990 to 1995. Diabetes Care 2007; 27: 1598-604.
9. Schofield CJ, Libby G, Brennan GM, Macalpine RR, Morris AD, Leese G. Mortality and hospitalizations in patients after amputations. Diabetes Care 2006; 29(10): 2252-6.
10. Khanolkar MP, Bain SC, Stephens JW. The diabetic foot. QJM 2008; 101(9): 685-95.
11. Boutoille D, Feraille A, Maulaz D, Krempf M. Quality of life with diabetes-associated foot complications: comparison between lower limb amputations and chronic foot ulceration. Foot Ankle Int 2008; 29(11): 1074-8.
12. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40(3): 163-73.
13. Allen KL. The potential for using honey to treat wounds infected with MRSA and VRE. First World Wound Healing Congress; Melbourne, Australia. September 12-13, 2000.
14. Vardi A, Barzilay Z, Linder N, et al. Local application of honey for treatment of neonatal postoperative wound infection. Acta Paediatr 1998; 87: 429-32.
15. Molan PC. The antibacterial properties of honey. Chem NZ 1995; 59: 10-4.
16. Tonkal AM, Morsy TA. An update review on Commiphora molmol and related species. J Egypt Soc Parasitol 2008; 38(3): 763-96.
17. Nomicos EY. Myrrh: medical marvel or myth of the Magi? Holist Nurs Pract 2007; 21(6): 308-23.
18. Dolara P, Corte B, Ghelardini C, et al. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med 2000; 66(4): 356-8.
19. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17(4): 299-305.
20. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005; 5(13-14): 1749-70.
21. Morsi NM. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 2000; 49(1): 63-74.
22. Tonks AJ, Cooper RA, Jones KP, et al. Honey stimulates inflammatory cytokine production from monocytes. Cytokine 2003; 21: 242-7.
23. Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001; 298: 865-72.
24. Postmes T, Vandeputte J. Recombinant growth factors or honey? Burns 1999; 25: 676-8.
25. Shati AA, Elsaid FG, Hafez EE. Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup. Neuroscience 2011; 175: 66-74.